Eli Lilly (LLY) Receivables - Other (2012 - 2026)
Eli Lilly (LLY) recorded Receivables - Other of $3.39 billion in Q2 2026, up 11.8% from $3.04 billion a year earlier and up 23.4% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Receivables - Other (2012 - 2026) Analysis & Trends
At the end of FY2025, Eli Lilly reported Receivables - Other of $2.4 billion, up 5.5% from FY2024.
- Annual Receivables - Other has increased for six straight years, with a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
- Across earlier years, Receivables - Other came in at $2.27 billion in FY2024 (+1.1%), $2.25 billion in FY2023 (+35.0%), $1.66 billion in FY2022 (+14.3%) and $1.45 billion in FY2021 (+38.0%).
- The Q2 2026 figure is the highest quarterly Receivables - Other in data going back to Q4 2012.
- On a year-over-year basis, Receivables - Other has increased for five consecutive quarters, with growth averaging 21.1% over the last eight quarters.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 90.7% in Q3 2025, against a decline of 20.0% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.75 billion (Q1 2026), $2.4 billion (Q4 2025) and $3.35 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 130.00 Bn | 102.01 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.39 Bn |
| Mar 31, 2026 | 2.75 Bn |
| Dec 31, 2025 | 2.40 Bn |
| Sep 30, 2025 | 3.35 Bn |
| Jun 30, 2025 | 3.04 Bn |
| Mar 31, 2025 | 1.97 Bn |
| Dec 31, 2024 | 2.27 Bn |
| Sep 30, 2024 | 1.76 Bn |
| Jun 30, 2024 | 2.05 Bn |
| Mar 31, 2024 | 2.13 Bn |
| Dec 31, 2023 | 2.25 Bn |
| Sep 30, 2023 | 2.20 Bn |
| Jun 30, 2023 | 1.66 Bn |
| Mar 31, 2023 | 1.50 Bn |
| Dec 31, 2022 | 1.66 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.31 Bn |
| Mar 31, 2022 | 1.48 Bn |
| Dec 31, 2021 | 1.45 Bn |
| Sep 30, 2021 | 1.11 Bn |
API Access
Eli Lilly Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();